Key result
COVID-19 in athletes shows ~3% myocarditis prevalence with LGE rates similar to athletic controls.
Why the study?
Investigations of the short- and long-term cardiovascular manifestations of COVID-19 are necessary to inform the optimal care of athletes recovering from infection and adjudicate safe return to athletic competition.
Absolute Event Rate: 27% vs 24%
p-value: p=0.56
Contextualizing abnormal CMR findings is imperative for adjudicating safe return to athletic competition in athletes recovering from COVID-19.
Supports cautious CMR interpretation in post-COVID athletes; leaves open optimal screening for safe return to play.
remains imperative when contextualizing abnormal CMR findings in the adjudication of a safe return to athletic competition.Ongoing investigations of the short-and long-term cardiovascular manifestations of COVID-19 are necessary to inform the optimal care of athletes recovering from infection.
No takes yet. Share an insight, caveat, or question.
Clark et al. (2020) conducted a letter in COVID-19 (n=146). COVID-19 infection vs. Healthy and athletic controls was evaluated on Any late gadolinium enhancement (LGE) compared to athletic controls (p=0.56). COVID-19 infection in collegiate athletes resulted in a 3% prevalence of myocarditis, while late gadolinium enhancement was similar to athletic controls (27% vs 24%, p=0.56), suggesting athletic remodeling rather than viral injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: